GAS6 and COVID-19: GAS6 was higher in COVID-19 and non–SARS-CoV-2 pneumonia patients > 70 years old and higher in COVID-19 patients with arterial hypertension, diabetes mellitus, and ischemic cardiopathy (Supplemental Figure 7); thus, age and comorbidities may confound interpretation of increased GAS6 in COVID-19.